Enochian Biosciences Inc·4

Aug 1, 9:28 PM ET

Dybul Mark 4

4 · Enochian Biosciences Inc · Filed Aug 1, 2019

Insider Transaction Report

Form 4
Period: 2019-07-30
Dybul Mark
Director
Transactions
  • Other

    Common Stock

    2019-07-30+10,68066,016 total
Footnotes (1)
  • [F1]On July 30, 2019, Mark Dybul, M.D. received 10,680 shares of common stock pursuant to a contractual right to receive shares upon the exercise of warrants by warrant holders of the Issuer.

Documents

1 file
  • 4
    ownership.xmlPrimary